Search Results

You are looking at 141 - 150 of 1,196 items for :

  • "characteristics" x
  • Refine by Access: All x
Clear All
Full access

Jamie M. Jacobs, Molly E. Ream, Nicole Pensak, Lauren E. Nisotel, Joel N. Fishbein, James J. MacDonald, Joanne Buzaglo, Inga T. Lennes, Steven A. Safren, William F. Pirl, Jennifer S. Temel, and Joseph A. Greer

. Research staff collected information about cancer diagnosis, oral therapy type, and other clinical characteristics from the EHR. Electronic Adherence Monitoring Participants were asked to store their oral therapy medication in pill bottles with electronic

Full access

Arif H. Kamal, Steve Power, Gloria Broadwater, Audrey R. Holland, and Paul K. Marcom

with patient characteristics, these profiles ensure that targeted therapies are selectively applied in delivering patient-centered care. A shining example of this has been the incorporation of trastuzumab for cancers that overexpress HER2, the use of

Full access

Joyce Valerie Veld, Femke Julie Amelung, Wernard Aat Antoine Borstlap, Emo Eise van Halsema, Esther Catharina Josephina Consten, Peter Derk Siersema, Frank ter Borg, Edwin Silvester van der Zaag, Paul Fockens, Willem Adrianus Bemelman, Jeanin Elise van Hooft, Pieter Job Tanis, and for the Dutch Snapshot Research Group

, potential eligible patients were first identified through the DCRA, and collaborators in each participating hospital were provided with their own patients registered in the DCRA. Subsequently, collaborators extended baseline characteristics and short

Full access

Lara Franziska Stolzenbach, Giuseppe Rosiello, Angela Pecoraro, Carlotta Palumbo, Stefano Luzzago, Marina Deuker, Zhe Tian, Anne-Sophie Knipper, Raisa Pompe, Kevin C. Zorn, Shahrokh F. Shariat, Felix K.H. Chun, Markus Graefen, Fred Saad, and Pierre I. Karakiewicz

version 3.4.1 (R Foundation for Statistical Computing). All tests were 2-sided with a level of significance set at P <.05. Results Descriptive Characteristics Of all 210,100 patients treated with RP, 4,704 (2.2%), 17,785 (8.4%), and 11,040 (5

Full access

Ashwin Rao, Nicole E. Rich, Jorge A. Marrero, Adam C. Yopp, and Amit G. Singal

, characteristic imaging [LI-RADS 5] or histopathologic confirmation). 25 We excluded patients (1) with liver masses without characteristic imaging or histology, (2) for whom the date of HCC presentation and/or diagnosis could not be ascertained from the

Full access

Alimujiang Wushou, Meng Wang, Feiluore Yibulayin, Lei Feng, Meng-meng Lu, Yuan Luo, Hui Liu, and Zhi-cheng Yang

resection of the primary tumor, in consideration of postoperative recurrence and poor prognosis due to the high rate of occult cervical metastasis in early OSCC. 13 Because of the lack of consensus in characteristics, study populations, and patient

Full access

Laura Bourdeanu, Thehang Luu, Norma Baker, Suzanne Swain-Cabriales, Cathie T. Chung, Joanne Mortimer, Arti Hurria, Sandra Helton, David Smith, Betty Ferrell, Gloria Juarez, and George Somlo

.8% Hispanic, 7.8% African American, and 10.5% Asian. The characteristics of the study population are shown in Table 2 . Patients experienced a range of 16- to 77-week delays (median, 24 weeks) to initiating chemotherapy treatment. For 75% of patients, the

Full access

Michael Xiang and Elizabeth A. Kidd

-Medicare linkage, patient follow-up was through December 2014. Statistical Analysis Baseline characteristics were compared using the chi-square or Wilcoxon rank-sum test. Multivariable logistic regression was used to identify predictors for receiving cisplatin

Full access

Ryan D. Nipp, Leah L. Thompson, Brandon Temel, Charn-Xin Fuh, Christine Server, Paul S. Kay, Sophia Landay, Daniel E. Lage, Lara Traeger, Erin Scott, Vicki A. Jackson, Nora K. Horick, Joseph A. Greer, Areej El-Jawahri, and Jennifer S. Temel

believed prohibited informed consent or study participation. Study Measures Sociodemographic and Clinical Characteristics Participants completed a demographic questionnaire to report their race, relationship status, work status, education level, annual

Full access

Renata R. Urban, Hao He, Rafael Alfonso-Cristancho, Melissa M. Hardesty, and Barbara A. Goff

, Patient Characteristics, and Treatment Identification This study identified all women older than 65 years diagnosed with ovarian cancer (n=26,379) in SEER cancer registries from January 1, 1995, to December 31, 2007. Women were excluded if they had a